Authors:
Michel, MC
Neumann, HG
Mehlburger, L
Schumacher, H
Goepel, M
Citation: Mc. Michel et al., Does the time of administration (morning or evening) affect the tolerability or efficacy of tamsulosin?, BJU INT, 87(1), 2001, pp. 31-34
Citation: Mc. Michel et M. Goepel, Lower urinary tract symptoms suggestive of benign prostatic obstruction - What's the long-term effectiveness of medical therapies?, EUR UROL, 39, 2001, pp. 20-25
Authors:
Hein, P
Goepel, M
Cotecchia, S
Michel, MC
Citation: P. Hein et al., A quantitative analysis of antagonism and inverse agonism at wild-type andconstitutively active hamster alpha(1B)-adrenoceptors, N-S ARCH PH, 363(1), 2001, pp. 34-39
Citation: Mc. Michel et M. Goepel, Treatment satisfaction of patients with lower urinary tract symptoms: Randomised controlled trials vs. real life practice, EUR UROL, 38, 2000, pp. 40-47
Authors:
Hein, P
Goepel, M
Cotecchia, S
Michel, MC
Citation: P. Hein et al., Comparison of [H-3]tamsulosin and [H-3]prazosin binding to wild-type and constitutively active alpha(1B)-adrenoceptors, LIFE SCI, 67(5), 2000, pp. 503-508
Authors:
Michel, MC
Mehlburger, L
Schumacher, H
Bressel, HU
Goepel, M
Citation: Mc. Michel et al., Effect of diabetes on lower urinary tract symptoms in patients with benignprostatic hyperplasia, J UROL, 163(6), 2000, pp. 1725-1729
Citation: M. Goepel, Characterization of alpha-adrenoceptor subtypes in the corpus cavernosum of patients undergoing sex change surgery (vol 162, pg 1793, 1999), J UROL, 163(6), 2000, pp. 1894-1894
Authors:
Keffel, S
Alexandrov, A
Goepel, M
Michel, MC
Citation: S. Keffel et al., alpha(1)-Adrenoceptor subtypes differentially couple to growth promotion and inhibition in Chinese hamster ovary cells, BIOC BIOP R, 272(3), 2000, pp. 906-911
Authors:
Goepel, M
Stohrer, M
Michel, MC
Scheulen, M
Schmidt, U
Rubben, H
Citation: M. Goepel et al., Autoaugmentation versus ileal augmentation of the neurogenic bladder: results of a prospective-randomized animal trial, AKT UROL, 31(3), 2000, pp. 181-188
Authors:
Stohrer, M
Goepel, M
Kondo, A
Kramer, G
Madersbacher, H
Millard, R
Rossier, A
Wyndaele, JJ
Citation: M. Stohrer et al., The standardization of terminology in neurogenic lower urinary tract dysfunction - With suggestions for diagnostic procedures, NEUROUROL U, 18(2), 1999, pp. 139-158
Authors:
Altwein, J
Aumuller, G
Berges, R
Dreikorn, K
Eickenberg, U
Engelmann, U
Gratzke, P
Harzmann, R
Haupt, G
Hofner, K
Jonas, D
Jonas, U
Krieg, M
Muschter, R
Pientka, L
Ringert, R
Schabel, J
Schuldes, H
Schweikert, U
Semjonow, A
Senge, T
Tunn, U
Tschuschke, C
Vogel, J
Weissbach, L
Weisser, H
Wirth, M
Zwergel, T
Zumbe, J
Palmtag, H
Goepel, M
Schalkhauser, K
Richter-Reichhelm, M
Alken, P
Huland, H
Jocham, D
Melchior, H
Stockamp, KF
Rubben, H
Thuroff, JW
Citation: J. Altwein et al., Guidelines of German urologists on the diagnosis of benign prostatic hyperplasia, UROLOGE, 38(3), 1999, pp. 297-303
Authors:
Stohrer, M
Goepel, M
Kramer, G
Lochner-Ernst, D
Rubben, H
Citation: M. Stohrer et al., Detrusormyectomy (autoaugmentation) in the treatment of hyperreflexive low-compliance bladder, UROLOGE, 38(1), 1999, pp. 30-37
Authors:
Goepel, M
Hecker, U
Krege, S
Rubben, H
Michel, MC
Citation: M. Goepel et al., Saw palmetto extracts potently and noncompetitively inhibit human alpha(1)-adrenoceptors in vitro, PROSTATE, 38(3), 1999, pp. 208-215
Authors:
Goepel, M
Krege, S
Price, DT
Michelotti, GA
Schwinn, DA
Michel, MC
Citation: M. Goepel et al., Characterization of alpha-adrenoceptor subtypes in the corpus cavernosum of patients undergoing sex change surgery, J UROL, 162(5), 1999, pp. 1793-1799
Authors:
Alexandrov, A
Keffel, S
Goepel, M
Michel, MC
Citation: A. Alexandrov et al., Differential regulation of 46 and 54 kDa jun N-terminal kinases and p38 mitogen-activated protein kinase by human alpha(1A)-adrenoceptors expressed in rat-1 cells, BIOC BIOP R, 261(2), 1999, pp. 372-376